Relmada Therapeutics, Inc. (RLMD)
NASDAQ: RLMD · Real-Time Price · USD
0.6100
-0.0601 (-8.97%)
At close: Jul 11, 2025, 4:00 PM
0.6110
+0.0010 (0.16%)
After-hours: Jul 11, 2025, 7:46 PM EDT

Relmada Therapeutics Market Cap

Relmada Therapeutics has a market cap or net worth of $20.25 million as of July 11, 2025. Its market cap has decreased by -77.55% in one year.

Market Cap
20.25M
Enterprise Value
-6.81M
1-Year Change
-77.55%
Ranking
Category
Stock Price
$0.61

Market Cap Chart

Since September 30, 2015, Relmada Therapeutics's market cap has decreased from $56.60M to $20.25M, a decrease of -64.23%. That is a compound annual growth rate of -9.97%.

History

DateMarket Cap% Change
Jul 11, 2025 20.20M 28.66%
Dec 31, 2024 15.70M -87.40%
Dec 29, 2023 124.60M 18.67%
Dec 30, 2022 105.00M -73.42%
Dec 31, 2021 395.00M -24.17%
Dec 31, 2020 520.90M 30.00%
Dec 31, 2019 400.70M 1,125.38%
Dec 31, 2018 32.70M 247.87%
Dec 29, 2017 9.40M -28.24%
Dec 30, 2016 13.10M -54.67%
Dec 31, 2015 28.90M -48.94%
View and export this data all the way back to 2015. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly and Company 711.91B
Johnson & Johnson 377.51B
AbbVie 339.94B
Novo Nordisk 305.41B
UnitedHealth Group 275.86B
Novartis AG 236.71B
Abbott Laboratories 229.69B
AstraZeneca 218.74B
Market Cap Rankings